CIK 0001674416
- Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- Operating
- EIN
- 473173478
- Phone
- +1 617-315-4600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- 4 Shares withheld for taxes Chief Executive Officer gave up 794 shares (to pay taxes)
- 4 Exercise or conversion Chief Executive Officer acquired 8,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Executive Officer gave up 741 shares (to pay taxes)
- 4 Open-market sale Director sold 42,000 shares at $67.41 ($2,831,388)
- 4 Open-market sale President sold 33,618 shares at $70.00 ($2,353,260)
- 4 Open-market sale Director sold 7,500 shares at $62.00 ($465,000)
- 4 Open-market sale Director sold 7,500 shares at $55.00 ($412,500)
- 4 Open-market sale Director sold 7,500 shares at $52.00 ($390,000)
- 4 Open-market sale Director sold 21,000 shares at $51.89 ($1,089,675)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Executive Officer gave up 740 shares (to pay taxes)
- 4 Shares withheld for taxes Executive VP, Head of R&D gave up 14,534 shares (to pay taxes)
- 4 Open-market sale Chief Business Officer sold 20,000 shares at an average $50.02 ($1,000,353)
- 4 Open-market sale President sold 50,000 shares at $50.00 ($2,500,065)
Page 16 of 26 · 502 filings